158 related articles for article (PubMed ID: 9542305)
1. [Seroprevalence of anti-human parvovirus B19 antibodies in a sample of blood donors in Galicia].
Mata Rebón M; Bartolomé Husson C; Bernárdez Hermida I
Enferm Infecc Microbiol Clin; 1998 Jan; 16(1):25-7. PubMed ID: 9542305
[TBL] [Abstract][Full Text] [Related]
2. [Prevalence of anti-human parvovirus B19 IgG antibody among blood donors in Jilin province].
Wei Q; Li Y; Wang JW; Wang H; Qu JG; Hung T
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):60-2. PubMed ID: 16816866
[TBL] [Abstract][Full Text] [Related]
3. [Investigation of parvovirus B19 seroprevalence in various age groups in Central Anatolia Region, Turkey].
Türk Dağı H; Ozdemir M; Baykan M; Baysal B
Mikrobiyol Bul; 2010 Jul; 44(3):467-72. PubMed ID: 21063997
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
[TBL] [Abstract][Full Text] [Related]
5. Parvovirus B19 and immune disorders.
Pugliese A; Beltramo T; Torre D; Roccatello D
Cell Biochem Funct; 2007; 25(6):639-41. PubMed ID: 16917962
[TBL] [Abstract][Full Text] [Related]
6. Seroepidemiology of human parvovirus B19 in Taiwan.
Lin KH; You SL; Chen CJ; Wang CF; Yang CS; Yamazaki S
J Med Virol; 1999 Feb; 57(2):169-73. PubMed ID: 9892403
[TBL] [Abstract][Full Text] [Related]
7. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection.
Pfrepper KI; Enders M; Motz M
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):362-5. PubMed ID: 16316402
[TBL] [Abstract][Full Text] [Related]
8. Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis.
Gonzalez B; Larrañaga C; León O; Díaz P; Miranda M; Barría M; Gaggero A
J Rheumatol; 2007 Jun; 34(6):1336-40. PubMed ID: 17477467
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of parvovirus B19 infection in Thai young adults.
Bhattarakosol P; Pancharoen C; Kowitdamrong E; Thammaborvorn R; Mungmee V
Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):585-8. PubMed ID: 15115134
[TBL] [Abstract][Full Text] [Related]
10. Incidence and clinical significance of parvovirus B19 infection in patients with rheumatoid arthritis.
Kozireva SV; Zestkova JV; Mikazane HJ; Kadisa AL; Kakurina NA; Lejnieks AA; Danilane IN; Murovska MF
J Rheumatol; 2008 Jul; 35(7):1265-70. PubMed ID: 18484700
[TBL] [Abstract][Full Text] [Related]
11. [Seroprevalence of B19 parvovirus infection in patients with acute polyarthritis].
Campoy Reolid E; Casanova Rituerto A; Rodríguez Moreno J; Gómez Vaquero C; Ros Expósito S; Roig Escofet D
Rev Clin Esp; 1996 Dec; 196(12):828-30. PubMed ID: 9132859
[TBL] [Abstract][Full Text] [Related]
12. [Seroprevalence of parvovirus B19 in patients with chronic idiopathic thrombocytopenic purpura].
Uslu H; Kiki I; Ozbek A; Erdem F; Ayyildiz A
Mikrobiyol Bul; 2007 Oct; 41(4):597-602. PubMed ID: 18173080
[TBL] [Abstract][Full Text] [Related]
13. A high prevalence of parvovirus B19 DNA in patients with psoriasis.
Yazici AC; Aslan G; Baz K; Ikizoglu G; Api H; Serin MS; Tezcan S; Emekdas G; Tasdelen B
Arch Dermatol Res; 2006 Oct; 298(5):231-5. PubMed ID: 16862431
[TBL] [Abstract][Full Text] [Related]
14. [Antibodies against human parvovirus B19 in the Madrid community].
de Ory F; Pachón I; Ramírez R; Echevarría JM
Enferm Infecc Microbiol Clin; 1999; 17(7):364-5. PubMed ID: 10535193
[No Abstract] [Full Text] [Related]
15. [Seroprevalence of human parvovirus B19 in ambulatory population of Cantabria, northern Spain].
Ruiz de Alegría Puig C; Balbás García de Bustos R; Herrera González MC; Martínez-Bernal MA
An Pediatr (Barc); 2009 Nov; 71(5):475-6. PubMed ID: 19783492
[No Abstract] [Full Text] [Related]
16. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection.
Hsu TC; Chen TY; Lin MC; Tzang BS; Tsay GJ
J Gastroenterol Hepatol; 2005 May; 20(5):733-8. PubMed ID: 15853987
[TBL] [Abstract][Full Text] [Related]
17. The burden of parvovirus B19 infection in women of childbearing age in England and Wales.
Vyse AJ; Andrews NJ; Hesketh LM; Pebody R
Epidemiol Infect; 2007 Nov; 135(8):1354-62. PubMed ID: 17291377
[TBL] [Abstract][Full Text] [Related]
18. Evidence for persistence of human parvovirus B19 DNA in bone marrow.
Cassinotti P; Burtonboy G; Fopp M; Siegl G
J Med Virol; 1997 Nov; 53(3):229-32. PubMed ID: 9365887
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of parvovirus B19 IgG in children affected by juvenile idiopathic arthritis.
Weissbrich B; Süss-Fröhlich Y; Girschick HJ
Arthritis Res Ther; 2007; 9(4):R82. PubMed ID: 17760961
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of anti-human parvovirus B19 antibodies in patients attending a centre for sexually transmitted diseases.
Salvatori L; Lavorino C; Giglio A; Alemanno L; Di Carlo A; Ameglio F; Caprilli F
New Microbiol; 1999 Jul; 22(3):181-6. PubMed ID: 10423735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
